Back to results
US 10,590,179 B2Granted
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
AssigneeCytlimic Inc.
InventorsTomoya Miyakawa, Masaaki Oka, Shoichi Hazama, Koji Tamada, Keiko Udaka
Life of this patent
Estimating the term…
Abstract
The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 11 and consisting of 11 or less amino acid residues.
Claims2
A method for treating or preventing cancer in a subject, comprising administering to the subject a peptide comprising 8 or more consecutive amino acid residues but 11 or less amino acid residues of SEQ ID NO:
- 4.
Dependencies are inferred from the claim text.